Skip to main content

Table 2 Cardiac MRI data according to presence or absence of late gadolinium enhancement

From: Myocardial characterization in pre-dialysis chronic kidney disease: a study of prevalence, patterns and outcomes

 LGEposn= 55LGEnegn= 104Pvalue
LVEDVI (ml/m2)61 ± 1259 ± 120.484
LVESVI (ml/m2)19 ± 818 ± 70.336
LVSV (ml)82 ± 1677 ± 170.095
LVEF (%)68 ± 1070 ± 80.382
LVMI (g/m2)66 ± 1462 ± 140.193
RVEDVI (ml/m2)67 ± 1468 ± 130.690
RVESVI (ml/m2)28 ± 1131 ± 100.057
RVSV (ml)78 ± 1774 ± 160.219
RVEF (%)62 ± 961 ± 70.405
LVH4 (7.3)4 (3.8)0.449
  1. Continuous variables are presented as mean ± SD if normally distributed or medians [25-75th percentile] for skewed variables. Categorical variables are presented as n (valid %). Significant p values are bold
  2. LVEDVI Left ventricular end-diastolic volume index. LVESVI Left ventricular end systolic volume index. LVSV Left ventricular stroke volume. LVEF Left ventricular ejection fraction. LVMI Left ventricular mass index. LVH Left ventricular hypertrophy. RVEDVI Right ventricular end diastolic volume index. RVESVI Right ventricular end systolic volume index. RVSV Right ventricular systolic volume. RVEF Right ventricular ejection fraction